Larvol Delta - A-Clinical-Trial-Evaluating-the-Safety-and-Efficacy-of-a-Single-Subretinal-Injection-of-AGTC501-in-Participants-With-XLRP

laruparetigene zovaparvovec (AGTC-501) - Beacon Therapeutics

http://clinicaltrials.gov/ct2/show/NCT04850118

Apr 8, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next